medicalxpress.com· Medical Xpress - Medications·· 14 hours agoPickScore72
Tegoprubart preserves kidney function better than tacrolimus in first-time transplant patients, trial suggests
In brief
The phase 2 BESTOW clinical trial showed that the anti-CD40L antibody tegoprubart better preserved transplanted kidney function than the standard of care tacrolimus in patients receiving a first kidney transplant, and significantly improved patient-reported quality of life.
Why it matters
Phase 2 trial shows anti-CD40L antibody beat tacrolimus in kidney protection and quality of life, early evidence for non-nephrotoxic immunosuppression.
Source: medicalxpress.com · medicalxpress.com